Elaine Mary Shannon
CIK: 0002009368
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)2 (66.7%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (33.3%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
TAK
TAKEDA PHARMACEUTICAL CO LTD
Officer
Discretionary Trading P&L
Holdings
About Shannon Elaine Mary
Shannon Elaine Mary (SEC CIK 0002009368) files insider reports with the SEC as Pres., Global Supply & Quality of TAKEDA PHARMACEUTICAL CO LTD (TAK).
Signal8 holds 4 ownership filings by Shannon Elaine Mary (1 Form 3, 3 Form 4), filed between Mar 18, 2026 and Aug 12, 2026. Those filings report 3 transactions, from Jul 1, 2026 to Aug 11, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Shannon Elaine Mary's filings is in LEXINGTON, MA.
Recent filings by Shannon Elaine Mary
Other insiders filing for TAKEDA PHARMACEUTICAL CO LTD (TAK)
- Duprey Lauren Rusckowski, Chief Transformation Officer
- Plump Andrew Stewart, President, R&D
- Greenway Nicola Deidre Petal, Chief Human Resources Officer
- Farajallah Awny Samaan Botros, Chief Medical Officer
- Ibrahim Ramy Riad Ahmed, President, PDT BU
- Pacheco Rhonda Janice, President, U.S. Business Unit